Castle Biosciences, Inc. (CSTL)

Last Closing Price: 33.41 (2026-11-19)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Castle Biosciences, Inc. (CSTL) had Net Income of $-4.10M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$102.89M
Net Income
$-4.10M
$23.92M
$78.97M
$105.62M
$-2.73M
$-1.07M
$-3.80M
$-3.80M
$-4.10M
$-4.10M
$-4.10M
$-4.10M
$-2.73M
$1.10M
30.63M
30.63M
$-0.13
$-0.13
Balance Sheet Financials
$356.86M
$111.46M
$222.55M
$579.41M
$67.61M
$6.15M
$33.35M
$100.96M
$478.44M
$386.95M
$478.44M
30.77M
Cash Flow Statement Financials
$12.81M
$-46.49M
$-5.05M
$116.73M
$77.99M
$-38.73M
$32.60M
--
--
Fundamental Metrics & Ratios
5.28
--
--
0.01
0.02
76.75%
-2.65%
-2.65%
--
-3.70%
-3.98%
$-15.76M
--
--
--
0.18
2.30
1.97
45.57
-0.86%
-1.06%
-0.71%
-0.85%
$15.55
$-0.51
$0.42